Hengrui Pharmaceutical

Jiangsu Hengrui Pharmaceuticals is a leading global pharmaceutical company headquartered in China, dedicated to the innovation and commercialization of high-quality medicines. The company maintains a diverse therapeutic focus, with significant strengths in oncology, metabolic diseases, autoimmune disorders, and anesthesiology. Hengrui's extensive R&D pipeline includes a wide array of modalities such as small molecules, monoclonal antibodies, and next-generation antibody-drug conjugates. With several proprietary drugs already approved and marketed in China, the company is aggressively expanding its international presence through global clinical trials and high-value licensing agreements with multinational pharmaceutical firms.